Fetal bradycardia secondary to magnesium sulfate therapy for preterm labor: A case report

S. L. Hamersley, H. J. Landy, M. J. O'Sullivan

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

BACKGROUND: Alterations in fetal heart rate variability and baseline may be seen with maternal administration of magnesium sulfate. In this case, a dose-related decrease in the baseline fetal heart rate was observed in association with magnesium sulfate administration. CASE: A primiparous woman was given parenteral magnesium sulfate for preterm labor. After tocolytic administration, the fetal heart rate baseline decreased to 110 beats per minute (bpm) from its initial rate of 140 bpm, although good variability was maintained. Increasing the dosage was accompanied by a further drop in the baseline heart rate, to 100 bpm. Fetal echocardiography was normal except for sinus bradycardia. Stopping magnesium sulfate administration was accompanied by a return to the pretherapy baseline heart rate. The pregnancy progressed without any further complications, and a healthy infant was delivered three weeks later. CONCLUSION: Maternal administration of magnesium sulfate may be associated with a profound decrease in the baseline fetal heart rate, resulting in fetal sinus bradycardia.

Original languageEnglish
Pages (from-to)206-210
Number of pages5
JournalJournal of Reproductive Medicine for the Obstetrician and Gynecologist
Volume43
Issue number3 SUPPL.
StatePublished - Apr 27 1998
Externally publishedYes

Fingerprint

Magnesium Sulfate
Premature Obstetric Labor
Bradycardia
Fetal Heart Rate
Heart Rate
Mothers
Tocolytic Agents
Therapeutics
Echocardiography
Pregnancy

Keywords

  • Bradycardia
  • Fetus
  • Labor
  • Magnesium sulfate
  • Premature

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Reproductive Medicine

Cite this

Fetal bradycardia secondary to magnesium sulfate therapy for preterm labor : A case report. / Hamersley, S. L.; Landy, H. J.; O'Sullivan, M. J.

In: Journal of Reproductive Medicine for the Obstetrician and Gynecologist, Vol. 43, No. 3 SUPPL., 27.04.1998, p. 206-210.

Research output: Contribution to journalArticle

@article{d2d95e9b8eb34e78a3705961914c3246,
title = "Fetal bradycardia secondary to magnesium sulfate therapy for preterm labor: A case report",
abstract = "BACKGROUND: Alterations in fetal heart rate variability and baseline may be seen with maternal administration of magnesium sulfate. In this case, a dose-related decrease in the baseline fetal heart rate was observed in association with magnesium sulfate administration. CASE: A primiparous woman was given parenteral magnesium sulfate for preterm labor. After tocolytic administration, the fetal heart rate baseline decreased to 110 beats per minute (bpm) from its initial rate of 140 bpm, although good variability was maintained. Increasing the dosage was accompanied by a further drop in the baseline heart rate, to 100 bpm. Fetal echocardiography was normal except for sinus bradycardia. Stopping magnesium sulfate administration was accompanied by a return to the pretherapy baseline heart rate. The pregnancy progressed without any further complications, and a healthy infant was delivered three weeks later. CONCLUSION: Maternal administration of magnesium sulfate may be associated with a profound decrease in the baseline fetal heart rate, resulting in fetal sinus bradycardia.",
keywords = "Bradycardia, Fetus, Labor, Magnesium sulfate, Premature",
author = "Hamersley, {S. L.} and Landy, {H. J.} and O'Sullivan, {M. J.}",
year = "1998",
month = "4",
day = "27",
language = "English",
volume = "43",
pages = "206--210",
journal = "The Journal of reproductive medicine",
issn = "0024-7758",
publisher = "Donna Kessel",
number = "3 SUPPL.",

}

TY - JOUR

T1 - Fetal bradycardia secondary to magnesium sulfate therapy for preterm labor

T2 - A case report

AU - Hamersley, S. L.

AU - Landy, H. J.

AU - O'Sullivan, M. J.

PY - 1998/4/27

Y1 - 1998/4/27

N2 - BACKGROUND: Alterations in fetal heart rate variability and baseline may be seen with maternal administration of magnesium sulfate. In this case, a dose-related decrease in the baseline fetal heart rate was observed in association with magnesium sulfate administration. CASE: A primiparous woman was given parenteral magnesium sulfate for preterm labor. After tocolytic administration, the fetal heart rate baseline decreased to 110 beats per minute (bpm) from its initial rate of 140 bpm, although good variability was maintained. Increasing the dosage was accompanied by a further drop in the baseline heart rate, to 100 bpm. Fetal echocardiography was normal except for sinus bradycardia. Stopping magnesium sulfate administration was accompanied by a return to the pretherapy baseline heart rate. The pregnancy progressed without any further complications, and a healthy infant was delivered three weeks later. CONCLUSION: Maternal administration of magnesium sulfate may be associated with a profound decrease in the baseline fetal heart rate, resulting in fetal sinus bradycardia.

AB - BACKGROUND: Alterations in fetal heart rate variability and baseline may be seen with maternal administration of magnesium sulfate. In this case, a dose-related decrease in the baseline fetal heart rate was observed in association with magnesium sulfate administration. CASE: A primiparous woman was given parenteral magnesium sulfate for preterm labor. After tocolytic administration, the fetal heart rate baseline decreased to 110 beats per minute (bpm) from its initial rate of 140 bpm, although good variability was maintained. Increasing the dosage was accompanied by a further drop in the baseline heart rate, to 100 bpm. Fetal echocardiography was normal except for sinus bradycardia. Stopping magnesium sulfate administration was accompanied by a return to the pretherapy baseline heart rate. The pregnancy progressed without any further complications, and a healthy infant was delivered three weeks later. CONCLUSION: Maternal administration of magnesium sulfate may be associated with a profound decrease in the baseline fetal heart rate, resulting in fetal sinus bradycardia.

KW - Bradycardia

KW - Fetus

KW - Labor

KW - Magnesium sulfate

KW - Premature

UR - http://www.scopus.com/inward/record.url?scp=0031893986&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031893986&partnerID=8YFLogxK

M3 - Article

C2 - 9564647

AN - SCOPUS:0031893986

VL - 43

SP - 206

EP - 210

JO - The Journal of reproductive medicine

JF - The Journal of reproductive medicine

SN - 0024-7758

IS - 3 SUPPL.

ER -